Your session is about to expire
← Back to Search
LTAE-PD Trial Summary
This trial will test the long term effects of aerobic exercise on the brain tissue, movement, mental functions, and driving in Parkinson's Disease patients.
- Parkinson's Disease
LTAE-PD Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
LTAE-PD Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
LTAE-PD Trial Design
Find a Location
Who is running the clinical trial?
- You don't have severe memory or thinking problems according to specific guidelines.Your aerobic fitness level is not very good for your age and gender, based on a cycling test.You have a valid driver's license and are currently able to drive.This study is open to both veterans and non-veterans.You have parkinsonism caused by medication or other conditions.You have a condition that includes symptoms similar to Parkinson's disease.You have had brain surgery for Parkinson's disease, like deep brain stimulation.Your vision is not clear enough (worse than 20/50) to drive safely.You have health conditions that make it unsafe for you to participate in exercise, according to the American College of Sports Medicine guidelines.You have a serious head injury or post-traumatic stress disorder (PTSD).You cannot have a brain MRI for medical reasons.People aged 40 and older diagnosed with Parkinson's disease according to specific criteria.You are at a certain stage of Parkinson's disease and have been on the same medication for at least 4 weeks before starting the study.Your aerobic fitness level is below what is considered very good for your age and gender during a cycling test.You do not have dementia according to specific criteria from the Movement Disorder Society.You have severe depression based on a test score called the Beck Depression Inventory (BDI).You have taken certain types of medications for mental health within the last 6 months.You have been diagnosed with dementia according to specific criteria.
- Group 1: Control
- Group 2: Aerobic
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are people with the required medical history still able to sign up for this research program?
"Correct, this research is ongoing and is recruiting participants, as stated on the clinicaltrials.gov website. The listing for this trial was first posted on 7/1/2019, and the most recent update was on 8/26/2022."
Why was this research project undertaken?
"The aim of this study, as evaluated by the change in Baseline Percent Increase Score (PIS) on Eriksen's flanker task over the course of a year, is to improve regional DTI. Additionally, this study will also monitor changes in motor function, ability to complete activities of daily living, and cognitive and memory skills."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends